Ekaterina Gibiansky

Generating author description...

All published works

Action	Title	Year	Authors
+	Tutorial: Numerical ( <scp>NONMEM</scp> ) Implementation of the Target‐Mediated Drug Disposition Model	2019	Leonid Gibiansky Ekaterina Gibiansky
+	Methods to detect non-compliance and reduce its impact on population PK parameter estimates	2014	Leonid Gibiansky Ekaterina Gibiansky Valérie Cosson Nicolas Frey Franziska Schaedeli Stark
+	Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model	2011	Leonid Gibiansky Ekaterina Gibiansky Robert J. Bauer
+	Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic–pharmacodynamic modeling of biologics	2009	Leonid Gibiansky Ekaterina Gibiansky
+	Optimizing a Bayesian Dose-Adjustment Scheme for a Pediatric Trial: A Simulation Study	2002	Marc R. Gastonguay Ekaterina Gibiansky Leonid Gibiansky Jeffrey S. Barrett
+	Optimizing a Bayesian Dose-Adjustment Scheme for a Pediatric Trial	2002	Jeffrey S. Barrett Marc R. Gastonguay Ekaterina Gibiansky Leonid Gibiansky
+	Population pharmacokinetics : model-free approach and nonlinear mixed-effects modelling	1999	Ekaterina Gibiansky
+	Performance of Bailer's method for AUC confidence intervals from sparse non-normally distributed drug concentrations in toxicokinetic studies.	1996	Sudhakar M. Pai Jerry Nedelman Gerald Hajian Ekaterina Gibiansky Vijay Batra
+	INFERRING SYSTEMIC EXPOSURE FROM A PHARMACOKINETIC SCREEN: MODEL‐FREE AND MODEL‐BASED APPROACHES	1995	Jerry Nedelman Adel H. Karara Cheng‐Tao Chang Ekaterina Gibiansky Scott McDonald William T. Robinson
+	Applying Bailer's method for AUC confidence intervals to sparse sampling.	1995	Jerry Nedelman Ekaterina Gibiansky David T. W. Lau

Common Coauthors

Coauthor	Papers Together
Leonid Gibiansky	6
Jerry Nedelman	3
Marc R. Gastonguay	2
Jeffrey S. Barrett	2
Franziska Schaedeli Stark	1
Adel H. Karara	1
Sudhakar M. Pai	1
Valérie Cosson	1
Cheng‐Tao Chang	1
Vijay Batra	1
Nicolas Frey	1
David T. W. Lau	1
William T. Robinson	1
Scott McDonald	1
Gerald Hajian	1
Robert J. Bauer	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	None	2000	David J. Lunn Andrew C. Thomas Nicky Best David J. Spiegelhalter	2
+	Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients.	1998	M. O. Karlsson E. Niclas Jonsson Curtis G. Wiltse Janet R. Wade	1
+	Mixed‐Effects Models	2007	Michael J. Crawley	1
+	Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncompliance.	2001	Jianfeng Lü Jean‐Michel Gries Davide Verotta Lewis B. Sheiner	1
+	The power of outliers (and why researchers should ALWAYS check for them)	2004	Jason W. Osborne Amy Overbay	1
+ PDF Chat	Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine	1992	Marie Davidian A. Ronald Gallant	1
+	Nonlinear Mixed Effects Models for Repeated Measures Data	1990	Mary J. Lindstrom Douglas M. Bates	1
+	Do we need full compliance data for population pharmacokinetic analysis?	1996	Pascal Girard Lewis B. Sheiner Helen Kastrissios Terrence F. Blaschke	1
+	Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model	2011	Leonid Gibiansky Ekaterina Gibiansky Robert J. Bauer	1
+	Nonparametric EM Algorithms for estimating prior distributions	1991	Alan Schumitzky	1
+	Mixed-Effects Nonlinear Regression for Unbalanced Repeated Measures	1992	Edward F. Vonesh Randy L. Carter	1
+	Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic–pharmacodynamic modeling of biologics	2009	Leonid Gibiansky Ekaterina Gibiansky	1
+	Controversy IV: Population Pharmacokinetics, NONMEM and the Pharmacokinetic Screen; Academic, Industrial and Regulatory Perspectives	1989	Wayne A. Colburn	1
+	A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples	2007	Robert J. Bauer Serge Guzy Chee M. Ng	1
+	Maximum likelihood estimation in nonlinear mixed effects models	2004	Estelle Kuhn Marc Lavielle	1
+	Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects	1992	Jaap W. Mandema Davide Verotta Lewis B. Sheiner	1
+	Estimation of Population Pharmacokinetic Parameters in the Presence of Non-compliance	2003	Song Mu Thomas M. Ludden	1
+ PDF Chat	Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0	2009	Caroline Bazzoli Sylvie Retout France Mentré	1
+	Population Pharmacokinetics of Cetuximab in Patients With Squamous Cell Carcinoma of the Head and Neck	2008	Nathanae L. Dirks Arno Nolting Andreas Kovar Bernd Meibohm	1
+	Population one-compartment pharmacokinetic analysis with missing dosage data	2004	Dolors Soy Stuart L. Beal Lewis B. Sheiner	1
+ PDF Chat	Variance Function Estimation	1987	Marie Davidian Raymond J. Carroll	1
+	Alternative Approaches to Estimation of Population Pharmacokinetic Parameters: Comparison with the Nonlinear Mixed-Effect Model	1984	Jean‐Louis Steimer Alain Mallet Jean‐Louis Golmard Jean-François Boisvieux	1
+	A Bayesian approach for the estimation of patient compliance based on the last sampling information	2011	Olivier Barrière Jun Li Fahima Nekka	1
+	A Probability Distribution and its Uses in Fitting Data	1979	John S. Ramberg Edward J. Dudewicz Pandu R. Tadikamalla Edward F. Mykytka	1
+	An alternative method for population pharmacokinetic data analysis under noncompliance	2008	Pankaj Gupta Matthew M. Hutmacher Bill Frame Raymond Miller	1
+ PDF Chat	THE IMPACT OF PATIENT COMPLIANCE ON DRUG CONCENTRATION PROFILE IN MULTIPLE DOSES	1996	Wen‐Ping Wang FRANCIS HUSAN Shein‐Chung Chow	1
+	Monte Carlo Parametric Expectation Maximization (MC-PEM) Method for Analyzing Population Pharmacokinetic/Pharmacodynamic Data	2006	Robert J. Bauer Serge Guzy	1
+	Statistical methodology in the pharmaceutical sciences	1991		1
+	Applying Bailer's method for AUC confidence intervals to sparse sampling.	1995	Jerry Nedelman Ekaterina Gibiansky David T. W. Lau	1